Patent · US Active

Consensus dengue virus envelope protein domain III polypeptides (cED III) and their methods of use

US7981431B2 · kind B2 · utility

0Cited by
0References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 4, 2008
Grant dateJul 19, 2011
Priority date
Expiry dateDec 6, 2028

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A consensus peptide sequence designed for domain III of the envelope proteins of four serotypes of dengue virus and used in a vaccine against multiple serotypes of dengue virus is disclosed. The vaccine is able to elicit cross-neutralization antibody responses against multiple serotypes of dengue virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.